Lung Cancer-on-Chip Platforms Model NSCLC

News   Oct 11, 2017 | Original story from the Wyss Institute

 
Lung Cancer-on-Chip Platforms Model NSCLC

This image shows how NSCLC adenocarcinoma cells can be grown as a tumor cell colony (blue) next to normal human small airway cells (purple) in the lung epithelial channel of the Lung Cancer Chip. Credit: Wyss Institute at Harvard University

 
 
 

RELATED ARTICLES

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.

READ MORE

Targeting Epigenetic Proteins to Prevent Breast Cancer

News

Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease.

READ MORE

Glial-Neuronal Interaction Fundamental for Memory

News

When astrocytes in mice overproduce a protein called ephrin-B1, the ability of the animal to retain memory weakens.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy